Prescription drug · ANDA
Gatifloxacin NDC 69315-331
Gatifloxacin anhydrous 5 mg/mL · Solution · Ophthalmic · Leading Pharma, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69315-331-02 | 69315033102 | 2.5 mL in 1 BOTTLE (69315-331-02)Marketed from Oct 6, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Gatifloxacin
- Generic name (nonproprietary)
- gatifloxacin
- Active ingredients
- Gatifloxacin anhydrous — 5 mg/mL
- Dosage form
- Solution
- Route
- Ophthalmic
- Labeler
- Leading Pharma, LLCNDC labeler code 69315
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213542
- Marketing start
- Listing expires
- Other FDA classes
- Quinolones (Chemical structure)
- Identifiers
- Product ID 69315-331_14b4bf1f-07ed-4578-96ac-47fc9c7c058bSPL ID 14b4bf1f-07ed-4578-96ac-47fc9c7c058bSPL set ID 826cf8c4-4be5-4614-bd42-47c1d0c9df58RxCUI 992395UNII 81485Y3A9AUPC 0369315331026
- Pharmacologic class
- Quinolone Antimicrobial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469315033102followed by a unit qualifier and the quantityPackage 69315-0331-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Gatifloxacin ophthalmic solution 0.5 % is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic gram-positive bacteria: Staphylococcus aureus Staphylococcus epidermidis Streptococcus mitis group * Streptococcus oralis* Streptococcus pneumoniae Aerobic gram-negative bacteria: Haemophilus influenzae *Efficacy for these organisms were studied in fewer than 10 infections. Gatifloxacin ophthalmic solution 0.5 % is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Stre…
Excerpt only. Read the full label for complete information.
About NDC 69315-331
- What is NDC 69315-331?
- 69315-331 is the product NDC for Gatifloxacin, Gatifloxacin anhydrous 5 mg/mL solution, listed with the FDA by Leading Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Gatifloxacin.
- What is the active ingredient?
- Gatifloxacin anhydrous.
- Who is the labeler?
- Leading Pharma, LLC, NDC labeler code 69315. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Gatifloxacin?
- 1 other product NDC are listed under this name. See all Gatifloxacin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Gatifloxacin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Gatifloxacin | Gatifloxacin 5 mg/mL | Solution/ dropsOphthalmic | Sandoz Inc | 61314-672 | 61314-0672-25 |
Other NDCs under ANDA 213542
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Gatifloxacin Ophthalmic Solution 0.5% | Gatifloxacin anhydrous 5 mg/mL | SolutionOphthalmic | Caplin Steriles Limited | 65145-207 |